Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Preferably interferon beta-1b should be stored at room temperature,
68 F to 77 F (20 C to 25 C).
It may be stored at 59 F to 86 F (15 C to 30 C) for
up to 3 months.
After dilution, it should be used immediately or refrigerated
and used within 3 hours.
The recommended dose is 0.25 mg every other day.
Treatment is started at
0.0625 mg (0.25 mL) every other day, and increased over a six-week period to
reach the target dose of 0.25 mg every other day.
DRUG CLASS AND MECHANISM:
Interferon beta-1b is a protein produced by recombinant DNA technology using
E. coli bacteria into which the human interferon beta genes have been
introduced. It is used for treating
multiple sclerosis (MS). Interferon beta has
antiviral properties and plays a role in regulating the immune response. The
exact mechanism by which interferon beta-1b works in the body to treat MS is not
known. Interferon beta-1b does not cure MS. Rather, it helps to decrease the
number of flare-ups and slows the occurrence of some of the physical disability
that commonly occurs in the disease.
Interferon beta-1b was approved by the FDA in July, 1993.